Skip to main content

Advertisement

Table 1 Final diagnosis categories.

From: Collectives of diagnostic biomarkers identify high-risk subpopulations of hematuria patients: exploiting heterogeneity in large-scale biomarker data

Individual patient final diagnosis n Final diagnosis category Group Total
No diagnosis 36 No diagnosis NLT 36
Category total     36
Fistula 1 Benign NLT  
Endometriosis 1 Benign NLT  
Trauma 1 Benign NLT  
Renal trauma 1 Benign NLT  
Renal cyst 1 Benign NLT  
Squamous Metaplasia 1 Benign NLT  
Category total     6
Stone 9 Stones/inflammation NLT  
Stone(s) with inflammation 2 Stones/inflammation NLT  
Stone with UTI 1 Stones/inflammation NLT  
Urinary tract infection 1 Stones/inflammation NLT  
Inflammation 4 Stones/inflammation NLT  
Category total     17
BPE with stone 2 BPE NLT  
BPE 10 BPE NLT  
Category total    NLT 12
Renal cell carcinoma with BPE 1 Other cancers LT  
Renal cell carcinoma 2 Other cancers LT  
Prostate cancer 3 Other cancers LT  
Category total     6
UC kidney ureter 1 NMI UC LT  
NMI TCC with stone 2 NMI UC LT  
NMI TCC with BPE 1 NMI UC LT  
NMI TCC 58 NMI UC LT  
Category total     62
MI UC with stone 2 MI UC LT  
MI UC with BPE 2 MI UC LT  
MI UC 14 MI UC LT  
Category total     18
TOTAL   157
  1. The final diagnosis was determined individually for each patient. The decision was based on history, physical examination, urinary tract radiological and endoscopy findings and also the pathological reports relating to biopsy or resection specimens. Based on their final diagnosis, each patient was assigned to one of the seven final diagnosis categories. For statistical purposes these categories were split into non-life threatening (NLT) or life threatening (LT) groups. BPE, benign prostate enlargement; MI muscle invasive; n, number; NMI, non-muscle invasive; TCC transitional cell carcinoma; UC, urothelial cancer; UTI, urinary tract infection.